Daily Health Pharmacy

Huntington’s Disease: Understanding Genetics, Chorea, and Real-Life Care Planning

Huntington’s Disease: Understanding Genetics, Chorea, and Real-Life Care Planning
28 December 2025 8 Comments Roger Donoghue

When someone is diagnosed with Huntington’s disease, the conversation rarely ends with a single doctor’s visit. It starts a long, complex journey - one that involves genetics you can’t change, movements you can’t control, and care plans that must be built while you’re still able to help shape them.

The Genetics Behind Huntington’s Disease

Huntington’s disease isn’t something you catch. It’s something you inherit. If one of your parents has the mutated gene, you have a 50% chance of getting it too - no matter your gender, where you live, or how healthy you are. This isn’t a guess. It’s math. Every child of an affected parent has exactly that same risk.

The problem lies in a tiny glitch on chromosome 4. A sequence of three letters - CAG - repeats too many times in the HTT gene. Normal is 10 to 26 repeats. Anything over 40 means the disease will develop. Between 36 and 39, it’s uncertain - some people get symptoms, others don’t. And then there’s the gray zone: 27 to 35 repeats. You won’t get HD, but your kids might. That’s because these repeats can grow bigger when passed down, especially from fathers.

Paternal inheritance is the big red flag for early-onset HD. About 85% of cases that start before age 20 come from the father. Why? Because sperm cells are more likely to add extra CAG repeats than egg cells. A father with 45 repeats might pass on 55. That’s enough to trigger juvenile HD - a more aggressive form with seizures, stiffness, and rapid decline.

There’s no way to fix the gene yet. But knowing your repeat count changes everything. Genetic testing is available, but it’s not taken lightly. Many at-risk people delay testing because of fear, stigma, or the emotional weight of knowing. Over 70% of those who test positive say they wished they’d done it sooner - not because they wanted to know, but because they needed time to plan.

What Chorea Really Looks Like

Chorea is the signature symptom of Huntington’s. It’s not just fidgeting. It’s not tics. It’s involuntary movements that seem to come from nowhere - a shoulder shrug, a finger twitch, a foot dragging, a head jerking. These movements flow from one part of the body to another, like a ripple. They disappear when you sleep. They get worse when you’re stressed, tired, or trying to focus.

Doctors measure chorea using the Unified Huntington’s Disease Rating Scale (UHDRS). A score of 1 means mild, occasional movements. A score of 4 means constant, severe motion that interferes with sitting, walking, or eating. Early on, chorea might be mistaken for restlessness or anxiety. Later, it can make holding a cup, typing, or even speaking nearly impossible.

The root cause? The brain’s striatum - a region that helps control movement - slowly dies. Neurons that use GABA, a calming chemical, are the first to go. As they disappear, the brain loses its brakes. The result? Uncontrolled motion.

There are two FDA-approved drugs for chorea: tetrabenazine (Xenazine) and deutetrabenazine (Austedo). Both work by lowering dopamine levels in the brain. They can reduce chorea by 25% to 30%. But they come with trade-offs. Depression hits 22% of users. Fatigue and sedation are common. Some people feel numb - emotionally and physically. Others say the drugs make them feel like they’re watching themselves from outside their body.

Valbenazine (Ingrezza), approved in 2023, offers a slightly different profile. It’s less likely to cause depression, but it’s not a cure. It just helps manage one part of a much bigger picture.

Invisible chorea movements leave colorful trails as a person struggles to hold a cup steady in a tilted room.

Care Planning: The Most Important Thing No One Talks About

Medications don’t stop Huntington’s from progressing. Therapy doesn’t reverse brain damage. The real lifeline? Care planning - started early, updated often, and built with the person’s voice at the center.

Most people wait too long. They wait until they can’t drive anymore. Until they can’t swallow safely. Until they’re in the hospital after a fall or a choking episode. But by then, it’s too late to make clear choices.

True care planning begins at diagnosis. It includes:

  • Legal documents: A living will, healthcare proxy, and power of attorney. Only 37% of people in general neurology clinics complete these. At specialized HD centers, it’s 82%.
  • Financial planning: HD care costs an average of $125,000 per year by the late stage. Most insurance doesn’t cover home modifications, therapy, or full-time caregivers. Out-of-pocket spending hits $5,000 a year for 42% of U.S. families.
  • Work and housing: Can you keep working? Should you apply for disability? Is your home safe for someone who stumbles often? Many people don’t ask these questions until it’s too late.
  • Communication: Talking to kids about genetic risk. Telling friends why you’re moving differently. Explaining to strangers that the jerking isn’t drunk behavior. These conversations are exhausting - but necessary.

Specialized HD centers - there are 53 in the U.S. - coordinate neurologists, therapists, social workers, and counselors. They hold quarterly team meetings. They track UHDRS scores. They adjust care as the disease changes. Patients who get this kind of care live 2.3 years longer on average. They’re 32% less likely to be hospitalized for pneumonia. And they’re 58% less likely to die by suicide.

But here’s the problem: only 38% of U.S. neurologists follow these guidelines. In rural areas, it takes over two years to get a full care team assembled. Many patients never see a speech therapist until they’re choking. They don’t get physical therapy until they’ve fallen three times.

What Works in Daily Life

There’s no magic pill for HD. But everyday actions make a huge difference.

  • Physical therapy: Aquatic therapy is 35% more effective than land-based exercise for balance and mobility. Water supports the body, reduces fall risk, and lets people move more freely.
  • Speech therapy: By 10 years after diagnosis, nearly half of patients need help with slurred speech. Swallowing issues come next. Speech therapists teach safe eating techniques and recommend texture-modified foods.
  • Nutrition: Weight loss is common. Chorea burns calories. Swallowing becomes harder. High-calorie shakes, soft foods, and meal timing matter more than ever.
  • Home safety: Remove rugs. Install grab bars. Use non-slip mats. Switch to lever-style door handles. These aren’t luxuries - they’re survival tools.

And then there’s the emotional toll. Caregivers spend an average of 15 hours a week just coordinating appointments - between neurologists, therapists, psychiatrists, social workers. Many feel isolated. One caregiver on the HDSA forum wrote: “The hardest part isn’t the chorea or even knowing I’ll decline - it’s watching my family try to plan for my deterioration while I’m still here.”

A care team forms a circle of interlocking puzzle pieces, symbolizing coordinated HD support in a calm room.

The Future: Hope, But Not Yet

There’s real progress in research. Wave Life Sciences’ SELECT-HD trial showed a 38% drop in mutant huntingtin protein after 135 weeks. That’s the first time anyone has reduced the actual toxic protein in people with HD. Roche’s tominersen, though paused and restarted, is still being studied. Gene therapies are in early trials.

But even if one of these works tomorrow, it won’t help the 40,000+ Americans living with HD right now. They still need meals. They still need to get dressed. They still need someone to hold their hand when the world feels too loud.

As Dr. Rachel Andre at Johns Hopkins put it: “Even with successful gene therapies, comprehensive care planning will remain critical for the 40,000+ Americans currently living with HD symptoms.”

That’s the truth. Science might one day change the course of Huntington’s. But until then, care planning isn’t just helpful - it’s the only thing standing between dignity and chaos.

Can you get Huntington’s disease if neither of your parents has it?

No. Huntington’s disease is caused by an inherited genetic mutation. If neither parent has the mutated HTT gene, you cannot develop HD. Rare cases where someone appears to have no family history are usually due to misdiagnosis, early death of a parent before symptoms appeared, or non-paternity. Genetic testing can confirm whether the mutation is present.

Is chorea the only symptom of Huntington’s disease?

No. Chorea is the most visible symptom, but HD affects the whole person. Cognitive decline - trouble focusing, planning, or remembering - is common. Psychiatric symptoms like depression, irritability, and obsessive behaviors often appear before movement problems. By the late stages, people may lose the ability to speak, swallow, or walk. It’s a full-brain disease, not just a movement disorder.

How early should care planning start for someone with Huntington’s disease?

Care planning should start at diagnosis - even if symptoms are mild. The best outcomes happen when legal documents, financial plans, and care goals are set while the person can still make informed choices. Waiting until mobility or speech declines means decisions are made under pressure, often by overwhelmed family members. Starting early gives you control over your future.

Are there any treatments that stop Huntington’s disease from getting worse?

No. Current treatments only manage symptoms - like chorea, depression, or irritability. Medications like tetrabenazine or deutetrabenazine reduce involuntary movements, but they don’t slow brain degeneration. Research is underway for gene-targeting therapies, but none are approved yet. For now, the most effective tool to slow decline is comprehensive, coordinated care.

Why is genetic counseling so important before getting tested for Huntington’s disease?

Genetic testing for HD is life-changing. A positive result means you will develop the disease - with no cure available. Counseling helps people understand what the test can and cannot tell them, how to share results with family, and what emotional and practical support is available. Over 95% of people at risk who test at specialized centers receive pre-test counseling. Skipping it can lead to severe psychological harm.

What’s the average life expectancy after a Huntington’s disease diagnosis?

Most people live 15 to 20 years after symptoms begin. Juvenile HD progresses faster - often 10 to 15 years. The cause of death is usually complications like pneumonia, heart failure, or injury from falls. Access to comprehensive care can extend life by over two years and reduce hospitalizations and suicide risk.

What Comes Next?

If you or someone you love has been diagnosed with Huntington’s disease, don’t wait for the worst to happen before acting. Connect with a Huntington’s Disease Society of America (HDSA) Center of Excellence. Ask for a care coordinator. Start the legal and financial conversations now. Talk to your family. Write down your wishes.

There’s no easy path. But there is a better one - and it starts with planning before you’re forced to make decisions in crisis.

8 Comments

  • Image placeholder

    Fabian Riewe

    December 29, 2025 AT 11:27

    Man, I wish more neurologists knew about the 53 HDSA centers. My cousin got diagnosed last year and waited 18 months just to get a speech therapist. By then, she was already aspirating on soft foods. If you’re reading this and have HD or a family member who does-don’t wait. Call HDSA today. Seriously.

  • Image placeholder

    Henriette Barrows

    December 29, 2025 AT 11:55

    I’m a caregiver for my mom, and this post nailed it. The emotional toll isn’t just about the chorea-it’s watching someone you love slowly lose the ability to tell you what they want. We started legal stuff right after diagnosis. Best decision we ever made. Still sucks, but at least she’s in control.

  • Image placeholder

    Joe Kwon

    December 31, 2025 AT 01:31

    From a clinical genetics standpoint, the paternal CAG expansion bias is one of the most robust phenomena in autosomal dominant disorders. The replication slippage in spermatogenesis is well-documented-meiotic recombination dynamics favor greater instability in male germlines. This has direct implications for preimplantation genetic diagnosis protocols and cascade testing strategies. Also, the 27–35 repeat range is now officially classified as ‘intermediate allele’ per ACMG guidelines. Important for counseling.

  • Image placeholder

    Sharleen Luciano

    January 1, 2026 AT 10:01

    Ugh. Another feel-good article pretending that ‘care planning’ is the real solution. Let’s be real-no one cares about your living will when you’re drooling in a wheelchair. Gene therapy is the only thing that matters. All this ‘aquatic therapy’ and ‘non-slip mats’ is just palliative distraction. If you’re not chasing CRISPR or ASOs, you’re just delaying the inevitable with Band-Aids.

  • Image placeholder

    Jim Rice

    January 1, 2026 AT 21:43

    Wait-so you’re saying if your dad had it, you’re screwed? What if he lied about his diagnosis? Or maybe he didn’t even have it? My uncle was diagnosed at 50 but lived to 80 with ‘twitches.’ Maybe HD is overdiagnosed? I’ve seen people get labeled with this just because they’re clumsy.

  • Image placeholder

    Lisa Dore

    January 1, 2026 AT 22:45

    Just wanted to say thank you for writing this. My sister got tested last year and was terrified. She didn’t tell anyone for months. But after reading this, she finally reached out to her local HDSA center. They helped her set up a care team, get financial aid, even talked to her kids about genetics. She’s not ‘fixed’-but she’s not alone anymore. That’s everything.

  • Image placeholder

    Nisha Marwaha

    January 2, 2026 AT 07:37

    As someone from India where neurogenetics infrastructure is sparse, I can’t stress enough how critical centralized care teams are. Here, families often rely on one overworked neurologist who doesn’t even know about UHDRS. We need telehealth models, community liaisons, and culturally adapted counseling tools. HD isn’t just a Western disease-it’s global, and we’re failing the Global South.

  • Image placeholder

    Fabian Riewe

    January 4, 2026 AT 01:49

    ^^^ This. I work with a nonprofit that ships adaptive utensils and speech therapy guides to rural clinics in India and Nigeria. We don’t have gene therapies yet-but we can give someone a cup they can hold. That’s not charity. That’s dignity.

Write a comment